96% Covid vaccine doses administered since May 1 were at govt centres: MoS

Over 96 per cent (108.55 crore) of the total Covid vaccine doses administered in the country since May 1 were given at government centres, while 3.7 per cent (4.12 crore) were at private facilities

A medical worker administers a dose of Covid-19 vaccine to a visitor in Mumbai on September 27, 2021. (PTI Photo)
File photo: A medical worker administers a dose of Covid-19 vaccine to a visitor in Mumbai on September 27, 2021. (PTI Photo)
Press Trust of India New Delhi
2 min read Last Updated : Dec 10 2021 | 3:31 PM IST

Over 96 per cent (108.55 crore) of the total Covid vaccine doses administered in the country since May 1 were given at government centres, while 3.7 per cent (4.12 crore) were at private facilities, the Lok Sabha was told on Friday.

As on December 7, a total of 4.61 crore doses of COVID-19 vaccines have been procured by private hospitals and 49 lakh doses are balance with them, Minister of State for Health Bharati Pravin Pawar said in a written reply to a question.

Under the 'Revised Guidelines for Implementation of National COVID Vaccination Program' effective from June 21, domestic vaccine manufacturers have the option to provide up to 25 per cent of their monthly vaccine production directly to private hospitals and any leftover vaccine is also procured by Government of India, Pawar said.

Responding to a question, Pawar said instances of fake Covid vaccination camps and/or fake vaccine from Maharashtra, West Bengal and Uttar Pradesh have come to the notice of the government.

The Ministry of Health has formally directed state governments to investigate these cases and take stringent legal and administrative actions so that such incidents are not repeated in the future, she said.

All states and UTs have also been asked to increase the vigilance within the supply chains and carefully authenticate the product and its physical condition before its use so as to guard against such unscrupulous activities, Pawar said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirus VaccineVaccination

First Published: Dec 10 2021 | 3:31 PM IST

Next Story